NYSE:ITGR - Integer Stock Price, Forecast & News

Integer trades on the New York Stock Exchange (NYSE) under the ticker symbol "ITGR."

Integer Holdings Corp (NYSE:ITGR) released its quarterly earnings results on Thursday, February, 20th. The medical equipment provider reported $1.25 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.18 by $0.07. The medical equipment provider had revenue of $325.60 million for the quarter, compared to analyst estimates of $321.68 million. Integer had a net margin of 7.66% and a return on equity of 13.83%. The firm's revenue was up 7.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.04 earnings per share. View Integer's Earnings History.

Integer is scheduled to release their next quarterly earnings announcement on Thursday, May 7th 2020. View Earnings Estimates for Integer.

Integer updated its FY20 earnings guidance on Thursday, February, 20th. The company provided earnings per share (EPS) guidance of $5.10-5.30 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.00. The company issued revenue guidance of $1.29-1.31 billion, compared to the consensus revenue estimate of $1.30 billion.

3 equities research analysts have issued twelve-month price targets for Integer's shares. Their forecasts range from $4.29 to $116.00. On average, they anticipate Integer's share price to reach $60.15 in the next twelve months. This suggests that the stock has a possible downside of 36.4%. View Analyst Price Targets for Integer.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Integer in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Integer.

Media stories about ITGR stock have been trending negative recently, InfoTrie reports. The research group rates the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Integer earned a news sentiment score of -2.1 on InfoTrie's scale. They also gave media headlines about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the immediate future. View News Stories for Integer.

Integer saw a decrease in short interest in the month of January. As of January 31st, there was short interest totalling 674,000 shares, a decrease of 16.3% from the January 15th total of 805,700 shares. Based on an average daily volume of 197,500 shares, the days-to-cover ratio is presently 3.4 days. Approximately 2.1% of the company's stock are sold short. View Integer's Current Options Chain.

Some companies that are related to Integer include Medtronic (MDT), Abbott Laboratories (ABT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Teleflex (TFX), Steris (STE), Insulet (PODD) and Hologic (HOLX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Integer investors own include Gilead Sciences (GILD), Lam Research (LRCX), Netflix (NFLX), Marathon Petroleum (MPC), Visa (V), Adobe (ADBE), Align Technology (ALGN), Broadcom (AVGO), Cerner (CERN) and Incyte (INCY).

Integer's stock is owned by many different of retail and institutional investors. Top institutional investors include State Street Corp (3.40%), Franklin Resources Inc. (2.36%), Geode Capital Management LLC (1.51%), Man Group plc (1.44%), Bank of New York Mellon Corp (1.32%) and Prudential Financial Inc. (1.27%). Company insiders that own Integer stock include Anthony W Borowicz, Bill R Sanford, Declan Smyth, Donald J Spence, Gary J Haire, James F Hinrichs, Jean M Hobby, Jennifer M Bolt, Jeremy Friedman, Jose Antonio Gonzalez, Joseph F Flanagan, Michael L Spencer, Pamela G Bailey, Peter H Soderberg, Timothy G Mcevoy and William B Summers Jr. View Institutional Ownership Trends for Integer.

ITGR stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Marshall Wace LLP, William Blair Investment Management LLC, PNC Financial Services Group Inc., Prudential Financial Inc., Chicago Equity Partners LLC, AQR Capital Management LLC and Stifel Financial Corp. Company insiders that have sold Integer company stock in the last year include Anthony W Borowicz, Donald J Spence, Jean M Hobby, Jose Antonio Gonzalez, Pamela G Bailey and Peter H Soderberg. View Insider Buying and Selling for Integer.

ITGR stock was purchased by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Standard Life Aberdeen plc, Man Group plc, Goldman Sachs Group Inc., California Public Employees Retirement System, Clark Capital Management Group Inc., Tamarack Advisers LP and Geode Capital Management LLC. View Insider Buying and Selling for Integer.

Shares of ITGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ITGR stock can currently be purchased for approximately $94.64.

Integer has a market capitalization of $3.10 billion and generates $1.26 billion in revenue each year. The medical equipment provider earns $96.34 million in net income (profit) each year or $4.68 on an earnings per share basis. Integer employs 8,250 workers across the globe.View Additional Information About Integer.

The official website for Integer is http://www.integer.net/.

Integer's mailing address is 5830 Granite Parkway Suite 1150, Plano TX, 75024. The medical equipment provider can be reached via phone at 214-618-5243 or via email at [email protected]